Skip to Main Content

Author Details

Mariel O Brok
Princess Maxima Center for Pediatric Oncology
1995
16
13
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35916583Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.EMBO Mol Med2022
32685929An Optimized Chromatin Immunoprecipitation Protocol for Quantification of Protein-DNA Interactions.STAR Protoc2020
33280256Genome-wide off-rates reveal how DNA binding dynamics shape transcription factor function.Mol Syst Biol2020
26700642A high-resolution gene expression atlas of epistasis between gene-specific transcription factors exposes potential mechanisms for genetic interactions.BMC Biol2015
24952590Cell cycle population effects in perturbation studies.Mol Syst Biol2014
24766815Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressors.Cell2014
23185333Exploring gene expression signatures for predicting disease free survival after resection of colorectal cancer liver metastases.PLoS One2012
21596317The specificity and topology of chromatin interaction pathways in yeast.Mol Cell2011
21145464Functional overlap and regulatory links shape genetic interactions between signaling pathways.Cell2010
18180247Improved genome-wide localization by ChIP-chip using double-round T7 RNA polymerase-based amplification.Nucleic Acids Res2008
15970668Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps.Cancer Biol Ther2005
15251980Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.Blood2004
12869630Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill.Mol Pharmacol2003
11854447Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype.Mol Pharmacol2002
12385009Deletion of chromosomal region 6q14-16 in prostate cancer.Int J Cancer2002
7632462Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.AIDS Res Hum Retroviruses1995
  • 1 - 16 of 16

Recommended Authors

Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Career Start Year 2012
Number of shared co-authors 1
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Katherine Licon
University of California San Diego
Career Start Year 2008
Number of shared co-authors 2
Anna Y Lee
Ontario Institute for Cancer Research
Career Start Year 2007
Number of shared co-authors 0
J Peter Svensson
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 1
Nizar N Batada
Institute of Genetics and Molecular Medicine, University of Edinburgh
Career Start Year 2004
Number of shared co-authors 0
Sean E Hanlon
Drew University, National Institutes of Health, Rutgers University New Brunswick, University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 0
Jiashun Zheng
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 4
Franco J Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2002
Number of shared co-authors 1
Erin M Green
University of Maryland Baltimore County
Career Start Year 2001
Number of shared co-authors 2
Assen Roguev
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Career Start Year 2000
Number of shared co-authors 3
Colm J Ryan
University College Dublin
Career Start Year 1999
Number of shared co-authors 5
Amy Hin Yan Tong
University of Toronto
Career Start Year 1999
Number of shared co-authors 2
Stephen Watt
Wellcome Sanger Institute
Career Start Year 1999
Number of shared co-authors 1
Jason Moffat
University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Peter H Thorpe
Queen Mary University
Career Start Year 1997
Number of shared co-authors 1
Patrice Menard
Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Career Start Year 1996
Number of shared co-authors 1
Christopher T Workman
Technical University of Denmark
Career Start Year 1995
Number of shared co-authors 0
Vishwanath R Iyer
Indian Institute of Technology Bombay
Career Start Year 1995
Number of shared co-authors 0
Manfred Koegl
Boehringer Ingelheim RCV GmbH & Co. KG
Career Start Year 1993
Number of shared co-authors 0
Marinella Gebbia
University of Toronto
Career Start Year 1989
Number of shared co-authors 3
Mike Tyers
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Career Start Year 1986
Number of shared co-authors 0
Yolanda Sanchez
Collegeville
Career Start Year 1985
Number of shared co-authors 0
Stanley Fields
University of Washington
Career Start Year 1985
Number of shared co-authors 2
Ralf Kittler
McDermott Center for Human Growth and Development.
Career Start Year 1984
Number of shared co-authors 0
Brenda J Andrews
University of Toronto
Career Start Year 1983
Number of shared co-authors 3
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 2
Michael Snyder
Stanford University
Career Start Year 1981
Number of shared co-authors 1
Michael Shales
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Career Start Year 1980
Number of shared co-authors 7
Philip Hieter
University of British Columbia
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Frank C P Holstege
Princess Maxima Center for Pediatric Oncology
Co-authored papers 10
Patrick Kemmeren
Princess Maxima Center for Pediatric Oncology
Co-authored papers 8
Marian J A Groot Koerkamp
Princess Maxima Center for Pediatric Oncology Research
Co-authored papers 7
Dik van Leenen
Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University
Co-authored papers 7
Philip Lijnzaad
Princess Maxima Center for Pediatric Oncology
Co-authored papers 6
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Co-authored papers 5
Tineke L Lenstra
the Netherlands Cancer Institute, Oncode Institute
Co-authored papers 5
Joris J Benschop
Center for Molecular Medicine, University Medical Center Utrecht
Co-authored papers 5
Thanasis Margaritis
Princess Maxima Center for Pediatric Oncology
Co-authored papers 4
Katrin Sameith
Center for Molecular and Cellular Bioengineering
Co-authored papers 4
Nathalie Brabers
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 4
Cheuk W Ko
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 3
Sake van Wageningen
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 3
Berend Snel
Utrecht University
Co-authored papers 3
Loes A L van de Pasch
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 3
Eva Apweiler
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 3
Linda V Bakker
Wageningen University and Research
Co-authored papers 2
Antony J Miles
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 2
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Dorothea Fiedler
Leibniz Forschungsinstitut fur Molekulare Pharmakologie (FMP)
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Hindrik H D Kerstens
Co-authored papers 1
Marc van de Wetering
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
Marijana Radonjic
Top Institute Food and Nutrition
Co-authored papers 1
Ines J de Castro
MRC London Institute for Medical Sciences
Co-authored papers 1
Virginia Taliadouros
Co-authored papers 1
Like Fokkens
University of Amsterdam
Co-authored papers 1
Rodrigo Aldecoa
Northeastern University
Co-authored papers 1
Michael S Kobor
University of British Columbia
Co-authored papers 1
Jayne Y Hehir-Kwa
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
Release 1.2